Lewes, DE -- (SBWIRE) -- 09/19/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Elite Pharmaceuticals Inc(OTCBB:ELTP), NanoTech Entertainment, Inc.(OTCMKTS:NTEK), OncoSec Medical Inc(OTCMKTS:ONCS), CANADIAN OIL SANDS(OTCMKTS:COSWF).
Elite Pharmaceuticals Inc(OTCBB:ELTP) ended higher +21.61% and complete the day at $0.130. The total number of shares changed hands during the day was 9.90 million. After opening at $0.11, the stock hit as high as $0.13. However, it traded between $0.05 and $0.13 over the last twelve months.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products. It develops orally administered controlled-release products for various therapeutic areas
For How Long ELTP will Fight for Profitability? Read This Trend Analysis report
NanoTech Entertainment, Inc.(OTCMKTS:NTEK) closed yesterday at $0.0981, a +12.76% increase. Around 9.38 million shares were traded, beating an-average trading volume of 3.92 million shares. The company is now valued at around $53.47 million.
NanoTech Entertainment, Inc. operates as a technology company with focus on entertainment industry worldwide. The company virtual manufactures and develops technology and games, and then licenses to coin-op arcade, casino gaming, and consumer gaming markets
For How Long NTEK Gloss will Attract Investors? Find out via this report
OncoSec Medical Inc(OTCMKTS:ONCS) moved -1.22 percent lower at $0.252 and traded between $0.18 and $0.49 after opening the day at $0.25. Its performance over the last five days remained -25.76%, which stands at -17.41% for a month. Going back further than one month, 1-year performance after recent close was 18.26%.
OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology
Why Should Investors Buy ONCS After the Recent Fall? Just Go Here and Find Out
CANADIAN OIL SANDS(OTCMKTS:COSWF) shares rose, gaining +1.16 percent to close at $19.64. The stock is down around -1.31% this year and -14.24% for the last 12 months. Around 94,144 shares changed hands yesterday, higher from an-average trading volume of 84,512 shares.
Canadian Oil Sands Limited, through its indirect interest in the Syncrude Joint Venture, engages in mining, extracting, and upgrading bitumen from oil sands in northern Alberta. It has 8 leases located in the Athabasca Oil Sands deposit covering 101,960 hectares. As of December 31, 2012, the company had proved plus probable reserves of 4.6 billion barrels of synthetic crude oil.
Why Should Investors Buy COSWF After The Recent Gain? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/